SAN JUAN, Puerto Rico, March 01, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has completed construction on the third of its five medical cannabis dispensary locations in Puerto Rico. The Company’s Carolina location is prepared for final inspection by the Department of Health of Puerto Rico (the “DHPR”). Once the location passes inspection and the DHPR issues the requisite Ocupational License for Establishment, Green Spirit may begin operations.
The new Green Spirit RX medicinal cannabis dispensary is located at 65th Infantry Avenue, Km 11.00, marginal 3, Lomas de Carolina, Puerto Rico, 00987. The dispensary is a safe, secure and beautifully appointed space where patients will be afforded both private consultation and a wide assortment of medicinal cannabis products for purchase. Located on the northeast coast of Puerto Rico, just east of San Juan and Trujillo Alto. Carolina is the fourth largest city in Puerto Rico. Home to Puerto Rico’s main airport, the Luis Muñoz Marin International Airport, Carolina is one of Puerto Rico’s most important tourist centers, with several well-known hotels on the coast in Isla Verde, as well as host to many entertainment events, including the 2003 and 2007 Caribbean World Series, is located in Carolina.
This Green Spirit RX medicinal cannabis dispensary, like the Company’s other locations in Puerto Rico, aims to offer patients an extensive selection of medicinal cannabis available for various methods of delivery, including inhalation, oral and topical. For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.
About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), together with its wholly-owned subsidiary, Project 1493, LLC, is in the business of acquiring, developing and operating medical cannabis dispensaries.
Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Contact:
Paul Gendreau
PGPR
[email protected]
678-807-7945


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



